Prophylaxis Against Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
Launched by TANTA UNIVERSITY · Aug 26, 2023
Trial Information
Current as of July 16, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well different medications can prevent nausea and vomiting after laparoscopic cholecystectomy, which is a surgery to remove the gallbladder. The researchers want to compare two groups: one group will receive dexmedetomidine and ondansetron, while the other group will receive dexamethasone and ondansetron. The main goal is to see how often patients experience nausea and vomiting after their surgery, but they will also look at how severe the nausea is, how often additional medication is needed, and the levels of pain and sedation following the procedure.
To participate in this study, you must be a female patient between the ages of 18 and 65 who is scheduled for elective laparoscopic cholecystectomy and in good health (ASA I or II, which means low risk for surgery). Unfortunately, those over 65 years old, under 18, or with certain health conditions like obesity or liver issues cannot take part. If you join the trial, you can expect to receive one of the two treatment options to help manage potential nausea during your recovery. This study is currently looking for participants, and your involvement could help improve care for future patients undergoing similar surgeries.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 70 Female patients aged between 18 and 65 years
- • ASA I or II
- • patients scheduled for elective laparoscopic cholecystectomy surgery will be included in this study.
- Exclusion Criteria:
- • Females above 65 years old.
- • patients under 18 years old.
- • ASA \> II.
- • Obesity (BMI\>40 kgm2).
- • Known hypersensitivity to drugs used in the study protocol.
- • Comorbidities that were known to increase the risk of PONV (e.g. vestibular disease).
- • Liver or renal dysfunction (liver enzyme or creatinine 1.5 times higher than normal).
- • Alcoholism or drug abuse.
- • Use of antiemetics and psychotropic drugs or glucocorticoids within 24 h before surgery.
About Tanta University
Tanta University is a prestigious academic institution located in Egypt, dedicated to advancing medical research and education. As a clinical trial sponsor, Tanta University leverages its extensive resources and expertise to conduct innovative research initiatives aimed at improving health outcomes. The university collaborates with a network of healthcare professionals, researchers, and institutions to facilitate rigorous clinical trials across various medical disciplines. Committed to ethical standards and scientific integrity, Tanta University strives to contribute to the global body of knowledge while fostering the next generation of medical professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, Gharbia, Egypt
Tanta, Algharbia, Egypt
Patients applied
Trial Officials
Mohamed A. Lotfy, PHD
Principal Investigator
Assistant Professor of Anesthesia and Intensive Care, Tanta Univ
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported